| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-22 19:49:26 UTC |
|---|
| Update Date | 2021-09-14 15:42:25 UTC |
|---|
| HMDB ID | HMDB0061125 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 4-Hydroxytamoxifen-O-glucuronide |
|---|
| Description | 4-Hydroxytamoxifen-O-glucuronide belongs to the class of organic compounds known as stilbene glycosides. Stilbene glycosides are compounds structurally characterized by the presence of a carbohydrate moiety glycosidically linked to the stilbene skeleton. 4-Hydroxytamoxifen-O-glucuronide is a very strong basic compound (based on its pKa). 4-hydroxytamoxifen-O-glucuronide and uridine 5'-diphosphate can be biosynthesized from 4-hydroxytamoxifen and uridine diphosphate glucuronic acid; which is catalyzed by the enzyme UDP-glucuronosyltransferase 1-4. In humans, 4-hydroxytamoxifen-O-glucuronide is involved in tamoxifen action pathway. 4-Hydroxytamoxifen-O-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. |
|---|
| Structure | CC\C(=C(/C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)C(O)=O)C=C1)C1=CC=CC=C1 InChI=1S/C32H37NO8/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(15-11-21)39-19-18-33(2)3)22-12-16-24(17-13-22)40-32-29(36)27(34)28(35)30(41-32)31(37)38/h5-17,27-30,32,34-36H,4,18-19H2,1-3H3,(H,37,38)/b26-25-/t27-,28-,29+,30-,32?/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C32H37NO8 |
|---|
| Average Molecular Weight | 563.6381 |
|---|
| Monoisotopic Molecular Weight | 563.251917165 |
|---|
| IUPAC Name | (2R,3R,4R,5S)-6-{4-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|
| Traditional Name | (2R,3R,4R,5S)-6-{4-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC\C(=C(/C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)C(O)=O)C=C1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C32H37NO8/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(15-11-21)39-19-18-33(2)3)22-12-16-24(17-13-22)40-32-29(36)27(34)28(35)30(41-32)31(37)38/h5-17,27-30,32,34-36H,4,18-19H2,1-3H3,(H,37,38)/b26-25-/t27-,28-,29+,30-,32?/m1/s1 |
|---|
| InChI Key | SSRNQFUJUAOPJD-FVLJLDENSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as stilbene glycosides. Stilbene glycosides are compounds structurally characterized by the presence of a carbohydrate moiety glycosidically linked to the stilbene skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Stilbenes |
|---|
| Sub Class | Stilbene glycosides |
|---|
| Direct Parent | Stilbene glycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Stilbene glycoside
- Phenolic glycoside
- 1-o-glucuronide
- O-glucuronide
- Diphenylmethane
- Glucuronic acid or derivatives
- Hexose monosaccharide
- Glycosyl compound
- O-glycosyl compound
- Phenylpropane
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Beta-hydroxy acid
- Monocyclic benzene moiety
- Hydroxy acid
- Monosaccharide
- Benzenoid
- Oxane
- Pyran
- Secondary alcohol
- Tertiary amine
- Tertiary aliphatic amine
- Amino acid or derivatives
- Amino acid
- Polyol
- Organoheterocyclic compound
- Acetal
- Carboxylic acid derivative
- Carboxylic acid
- Ether
- Oxacycle
- Monocarboxylic acid or derivatives
- Amine
- Organonitrogen compound
- Carbonyl group
- Organopnictogen compound
- Organic oxide
- Organooxygen compound
- Hydrocarbon derivative
- Alcohol
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.33 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.8534 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.54 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1921.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 222.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 201.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 214.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 141.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 507.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 607.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 738.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 987.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 548.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1328.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 358.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 429.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 298.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 357.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 4-Hydroxytamoxifen-O-glucuronide,1TMS,isomer #1 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4518.8 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,1TMS,isomer #2 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4508.5 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,1TMS,isomer #3 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4545.5 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,1TMS,isomer #4 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4485.0 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TMS,isomer #1 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4436.8 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TMS,isomer #2 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4464.0 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TMS,isomer #3 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4485.6 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TMS,isomer #4 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4417.3 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TMS,isomer #5 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4469.2 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TMS,isomer #6 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4454.0 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,3TMS,isomer #1 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4412.6 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,3TMS,isomer #2 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4449.6 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,3TMS,isomer #3 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4460.0 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,3TMS,isomer #4 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4420.4 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,4TMS,isomer #1 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4405.2 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,1TBDMS,isomer #1 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4702.6 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,1TBDMS,isomer #2 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4706.1 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,1TBDMS,isomer #3 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4742.7 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,1TBDMS,isomer #4 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4702.9 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TBDMS,isomer #1 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4816.3 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TBDMS,isomer #2 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4826.2 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TBDMS,isomer #3 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4830.0 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TBDMS,isomer #4 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]2O)C=C1)C1=CC=CC=C1 | 4812.3 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TBDMS,isomer #5 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4827.5 | Semi standard non polar | 33892256 | | 4-Hydroxytamoxifen-O-glucuronide,2TBDMS,isomer #6 | CC/C(=C(\C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4853.7 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9100430000-863d49e13792f7e245fc | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (1 TMS) - 70eV, Positive | splash10-0ab9-9310114000-0483951a9886bdaef469 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS ("4-Hydroxytamoxifen-O-glucuronide,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TMS_4_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 10V, Positive-QTOF | splash10-01w1-2219180000-073f810667570617d7fc | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 20V, Positive-QTOF | splash10-00dr-4229000000-313fd55c827594618aff | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 40V, Positive-QTOF | splash10-00dr-8349000000-c6d15303fee2ab9f9b73 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 10V, Negative-QTOF | splash10-03y0-2105190000-54437dcc8f02e6756b68 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 20V, Negative-QTOF | splash10-000i-2119230000-a43d99e75b3cf24e8df2 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 40V, Negative-QTOF | splash10-01p9-4119000000-9499803fb93cc62f9554 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 10V, Positive-QTOF | splash10-03di-0001190000-e1fd3141b3d2d9822a2f | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 20V, Positive-QTOF | splash10-00dj-5201890000-4fbfcee922d0ed46813e | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 40V, Positive-QTOF | splash10-00di-9100100000-9988d6a2fba17e0472d9 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 10V, Negative-QTOF | splash10-03di-0004090000-4a390c3c902b05b0c618 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 20V, Negative-QTOF | splash10-01pc-6209680000-ba441eff0800128da8d0 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen-O-glucuronide 40V, Negative-QTOF | splash10-03dr-1009100000-5172e256d94dbaf10114 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|